Our Global Service and Collaborators

map

U.S.

PERU

BRAZIL

ARGENTINA

U.K.

S.AFRICA

RUSSIA

INDIA

TAIWAN

AUSTRALIA

EffPha provides a full range of regulatory and clinical trial services

EffPha provides a full range of regulatory services and assists customers in outsourcing and managing EffPha’s partners to provide clinical trial services

EffPha assists customers in outsourcing and managing elite partners to provide complete regulatory and clinical trial services in the marked areas

Asia

Taiwan

Taiwan

EffPha provides strategic consulting services and full CRO services, including clinical operation, regulatory affairs, data management and statistical analysis.
Client: Pharmaceutical/ Biotech Company, Goverment Funded Research Center
Drug Type: Small Molecular/Botanical Drug, Biologics
Indication: Advanced Solid Tumors, Cancer, Diabetes Mellitus, Sepsis, Dermatology/ Inflammatory

China

China

EffPha supports clinical study and drug registration in Taiwan.
Client: Pharmaceutical Company
Drug Type: Small Molecular, Botanical Drug
Indication:Cancer, Stroke, Pain, Focal Segmental Glomerulosclerosis (FSGS)

Japan

Japan

Client: Pharmaceutical/Biotech Company, Venture
Investment Firm
Drug Type: Liposome
Indication: Inflammatory Disease

South Korea

South Korea

EffPha supports clinical study and drug registration in Taiwan.
Client: Pharmaceutical/Biotech Company, Venture Investment Firm
Drug Type: Small Molecular Drug, Biologics
Indication: Cancer

India

India

Client: Generic Pharmaceutical Company
Drug type: Small molecular
Indication: Cardiovascular Disease

America

US

US

EffPha serves as the regulatory representative in the US and provides regulatory affairs services to the clients.
Client: Pharmaceutical/Biotech Company, Venture Investment Firm
Drug Type: Small Molecular, Botanical Drug
Indication: Advanced Solid Tumors, Cancer, Diabetes Mellitus, Dermatitis

Canada

Canada

Client: Pharmaceutical Company, Venture Investment Firm

Europe

United Kingdom

United Kingdom

EffPha has partners that provide full CRO services in Europe.
Partner: Clinical Management Company
Drug Type: Small Molecular
Indication: Headache

Australia

Australia

Australia

EffPha supports clinical study and regulatory application in Taiwan.
Client: Pharmaceutical Company
Drug Type: Small Molecular Drug
Indication: Cancer Pain